Clinical Trials · NCT07602699
Multi-Site Trial of Tirzepatide for Smoking Cessation
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- University of Southern California
- Enrollment
- 300
- Start date
- May 2026
- Locations
- 4 sites, United States
- Primary endpoint
- 7-day point prevalence abstinence